Skip to main content
Book cover

Renal Cell Carcinoma

Molecular Features and Treatment Updates

  • Book
  • © 2017

Overview

  • Provides a comprehensive review of diagnosis and treatments of renal cell carcinoma

  • Presents the most recent advances in molecular bases and targeted therapy for renal cell carcinoma

  • Contains important information about pharmacokinetics and pharmacodynamics in molecular- targeted agents of renal cell carcinoma

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 chapters)

Keywords

About this book

This book provides a comprehensive review of diagnosis and treatments of renal cell carcinoma (RCC) for practitioners and researchers with an interest in this disease. A major aim of the book is to present the most important and most recent advances in molecular bases and targeted therapy for this neoplasm. The remarkable resistance to chemotherapy and radiotherapy and the minimum contribution of cancer genes that commonly mutate in other adult epithelial cancers have made RCC highly distinct from other types of solid neoplasms. In the past decade, however, treatment options for RCC have been expanding and moving quickly toward laboratory-based and molecular-targeted therapies. Advances in RCC therapy also have brought novel treatment options to other types of cancer, such as a TKI for hepatocellular carcinoma and gastrointestinal tumors, as well as mTOR inhibitors to progressive neuroendocrine tumors of pancreatic origin and to breast cancer, suggesting that RCC is no longer an "orphan disease" in the field of molecular oncology. Additional topics covered in the book include pharmacokinetics and pharmacodynamics in molecular-targeted agents and the putative mechanism of resistance to anti-angiogenic agents, such as intratumoral heterogeneity or cancer stem cell population. This volume provides the latest and most useful information for all readers who are eagerly devoted to curing renal cell carcinoma.




Editors and Affiliations

  • Department of Urology, Keio University School of Medicine, Tokyo, Japan

    Mototsugu Oya

About the editor

Dr. Mototsugu Oya Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Bibliographic Information

  • Book Title: Renal Cell Carcinoma

  • Book Subtitle: Molecular Features and Treatment Updates

  • Editors: Mototsugu Oya

  • DOI: https://doi.org/10.1007/978-4-431-55531-5

  • Publisher: Springer Tokyo

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Japan KK 2017

  • License: CC BY

  • Hardcover ISBN: 978-4-431-55530-8Published: 22 February 2017

  • Softcover ISBN: 978-4-431-56661-8Published: 19 July 2018

  • eBook ISBN: 978-4-431-55531-5Published: 14 February 2017

  • Edition Number: 1

  • Number of Pages: X, 381

  • Number of Illustrations: 24 b/w illustrations, 54 illustrations in colour

  • Topics: Oncology, Urology, Molecular Medicine

Publish with us